Related Experiment Video
Updated: Dec 21, 2025

RhoC GTPase Activation Assay
Published on: August 22, 2010
Dysregulation of Rho GTPases in Human Cancers
Haiyoung Jung1, Suk Ran Yoon1, Jeewon Lim1,2
1Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon 34141, Korea.
Abstract:
Rho GTPases play central roles in numerous cellular processes, including cell motility, cell polarity, and cell cycle progression, by regulating actin cytoskeletal dynamics and cell adhesion. Dysregulation of Rho GTPase signaling is observed in a broad range of human cancers, and is associated with cancer development and malignant phenotypes, including metastasis and chemoresistance. Rho GTPase activity is precisely controlled by guanine nucleotide exchange factors, GTPase-activating proteins, and guanine nucleotide dissociation inhibitors. Recent evidence demonstrates that it is also regulated by post-translational modifications, such as phosphorylation, ubiquitination, and sumoylation. Here, we review the current knowledge on the role of Rho GTPases, and the precise mechanisms controlling their activity in the regulation of cancer progression. In addition, we discuss targeting strategies for the development of new drugs to improve cancer therapy.
Insights
Rho GTPases are key regulators of cell functions. Their dysregulation drives cancer progression, and understanding their control mechanisms offers new therapeutic targets for cancer treatment.
Area of Science:
- Cell Biology
- Molecular Oncology
Background:
- Rho GTPases are crucial regulators of actin cytoskeleton dynamics, cell motility, polarity, and cell cycle.
- Their aberrant signaling is implicated in various human cancers, contributing to tumor development, metastasis, and chemoresistance.
Purpose of the Study:
- To review the role of Rho GTPases in cancer progression.
- To elucidate the mechanisms controlling Rho GTPase activity, including post-translational modifications.
- To discuss potential therapeutic strategies targeting Rho GTPase pathways in cancer therapy.
Main Methods:
- Literature review of current research on Rho GTPases in cancer.
- Analysis of regulatory mechanisms including guanine nucleotide exchange factors, GTPase-activating proteins, and GTPase-activating proteins.
- Examination of post-translational modifications like phosphorylation, ubiquitination, and sumoylation.
Main Results:
- Rho GTPase signaling is essential for normal cellular functions but its dysregulation promotes cancer.
- Activity of Rho GTPases is tightly controlled by specific regulatory proteins and post-translational modifications.
- Targeting Rho GTPase pathways presents a promising avenue for novel cancer therapies.
Conclusions:
- Rho GTPases are critical players in cancer progression, influencing key malignant phenotypes.
- Understanding the intricate regulatory network of Rho GTPases is vital for developing effective cancer treatments.
- Targeting Rho GTPase signaling pathways holds significant potential for improving cancer therapy outcomes.
More Related Videos
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
11:28Affinity Precipitation of Active Rho-GEFs Using a GST-tagged Mutant Rho Protein GST-RhoAG17A from Epithelial Cell Lysates
Published on: March 31, 2012
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a...
Cell Polarization by Rho Proteins
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation